Loss-of-function mutations in FAT1 and NF2 can result in enhanced YAP/TAZ protein accumulation, nuclear translocation, and the activation of transcription, leading to tumor progression, metastasis, and therapy resistance. Here, FAT1 is linked to neoplasm.